Quick Answer
Arcadia Biosciences, Inc. reported Operating Income Loss of -$2.50 million for the year ending 2025.
- Arcadia Biosciences, Inc. showed an increase of +31.5% in Operating Income Loss from 2024 to 2025.
- This data is from Arcadia Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2014: -$2.58 million | Q2 2014: -$5.00 million | Q3 2014: -$5.94 million | Q1 2015: -$3.71 million | Q2 2015: -$3.55 million | Q3 2015: -$4.24 million | Q1 2016: -$4.93 million | Q2 2016: -$4.29 million | Q3 2016: -$3.93 million | Q1 2017: -$3.96 million | Q2 2017: -$3.74 million | Q3 2017: -$3.62 million | Q1 2018: -$3.84 million | Q2 2018: -$4.58 million | Q3 2018: -$4.10 million | Q1 2019: -$4.22 million | Q2 2019: -$4.98 million | Q3 2019: -$6.19 million | Q1 2020: -$5.79 million | Q2 2020: -$6.88 million | Q3 2020: -$7.58 million | Q1 2021: -$5.33 million | Q2 2021: -$7.68 million | Q3 2021: -$8.71 million | Q1 2022: -$4.62 million | Q2 2022: -$3.78 million | Q3 2022: -$3.99 million | Q1 2023: -$3.87 million | Q2 2023: -$1.45 million | Q3 2023: -$1.40 million | Q1 2024: -$1.59 million | Q2 2024: $1.98 million | Q3 2024: -$1.76 million | Q1 2025: $530.0 thousand | Q2 2025: -$501.0 thousand | Q3 2025: -$1.15 million.
- Over the full 12 years of available data (2014 to 2025), Arcadia Biosciences, Inc.'s Operating Income Loss has grown by 83.5%.
- Historical annual values: Fiscal year 2025: -$2.50 million | Fiscal year 2024: -$3.65 million | Fiscal year 2023: -$6.10 million | Fiscal year 2022: -$14.01 million | Fiscal year 2021: -$35.53 million | Fiscal year 2020: -$12.78 million | Fiscal year 2019: -$19.38 million | Fiscal year 2018: -$16.87 million | Fiscal year 2017: -$14.32 million | Fiscal year 2016: -$18.62 million | Fiscal year 2015: -$15.56 million | Fiscal year 2014: -$15.15 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: